Centre for Eye Research Australia conducts research to address vision loss and blindness, with a focus on eye health and clinical trials.

Centre for Eye Research Australia

Centre for Eye Research Australia (CERA) focuses on research related to vision loss and blindness. It is involved in conducting clinical trials and studies to advance eye health.

Centre for Eye Research Australia (CERA)

Centre for Eye Research Australia (CERA) | 7,387 followers on LinkedIn. Hope in sight. | Vision is precious and no one should ever lose the gift of sight.

We’re deeply committed to conducting eye research with real-life impact and finding ways to prevent people from going blind.

As an international leader in eye research, we use our world-class knowledge and expertise to achieve better treatments, and faster diagnosis of eye disease.

Serge Scrofani

Head of I.T. Infrastructure

Richard Lee

Chief Technology Officer Burnet Institute and The Centre for Eye Research Australia.

Ian Briggs

Principal Investigator, Centre for Eye Research Australia

Ian Trounce

You're invited to join us next Tuesday 19 November as pioneering researcher Professor Jean Bennett and CERA scientists discuss the sight-saving potential of gene therapy at the 15th annual Gerard Crock Lecture. Hear about Professor Bennett’s role leading pivotal research that led to the development of the world’s first approved ocular gene therapy – Luxturna, a treatment for a rare genetic form of childhood blindness Leber Congenital Amaurosis, as well as what is on the horizon. Both in-person and online livestream tickets are free – but registrations are essential: https://lnkd.in/gbEabjrs Cerulea Clinical Trials , Faculty of Medicine, Dentistry and Health Sciences .

CERA researchers have successfully used an innovative gene therapy technique that could one day replace the need for regular eye injections for conditions including ‘wet’ age-related macular degeneration and diabetic eye disease. Their technique edits a person's RNA, which changes the genetic instructions that influence the way cells behave without permanently altering DNA. "We envision that RNA editing could become a viable alternative to invasive and costly eye injections that have become a fact of life for many people," says Head of Genetic Engineering Research Associate Professor Guei-Sheung (Rick) Liu. Read more: https://ow.ly/7n6350U2O0q

This weekend Heather Machin and Terry Couper from the Lions Eye Donation Service (LEDS) organised and presented at the Orthoptics Australia and Australian Ophthalmic Nurses Association Conferences that were held alongside the The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Adelaide Conference. LEDS is a multi-disciplined team of nurses, orthoptists, and medical scientists. Through team members like Terry and Heather, LEDS and CERA continue to support, engage and collaborate with the wider allied health care group to exchange knowledge and promote both eye care and eye banking.

Thank you to everyone who attended the Australian Ophthalmic Nurses Association National Conference at the The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Congress in Adelaide on the weekend. It was a great honour to be the Conference Convenor of such an amazing program, along side my co-Convenor Roseanna-Zoe Knowles. Special thanks to all our fantastic Speakers, Sponsors and Chairs who joined us from across Australia, New Zealand, Papua New Guinea and the USA ... and of course, a huge thanks our fabulous Committee who work voluntarily each and every day to propel forward ophthalmic nursing across Australia and beyond. Shout out to: Device Technologies , Alcon , Johnson & Johnson , Glaukos Corporation , Vision Hospital Group , ZEISS Group , Olga Brochner, Getruth Getruth Bare , Kylie Bennett , Terry Couper , Amanda Davis , Darren Gray , Vicky Heaton , Gabriela Kalofonos, Kerrie Legg , Christina L. , Joanna Mcculloch , Charis McKerrell , Peter Mitchell , Isabella Mou , Carmen Newman , Thuan Nguyen, Dr. Zali O'Dea , Damian Papps , Jessica Raab , Natasha Sikman, Val Tosswill , Tierney Mikolaj, Nicky Wyatt, Bernie Hanratty, Rhea Ortega , Lesley McDowell , Colleen Flanders and Knowles Brothers Wine . #AONA

Heather Machin, RN, MBA, PhD

🗞️ Our November edition of Eye News arrives in email inboxes across our wide CERA community tomorrow – packed full of the latest vision research, news and upcoming events! 📭 Have you subscribed❓ 👀 [link below in comments]

Congratulations to Assocaite Professor Raymond Wong on winning the recent TRAM Air Pitch Showcase Competition! Through his startup Mirugen , Associate Professor Wong and his team are aiming to develop a gene therapy able to regenerate cells lost in the retina. Their work has the potential to restore sight for people living with conditions like retinitis pigmentosa, age-related macular degeneration, and Stargardt disease. They have been supported towards this goal by Translating Research at Melbourne through the 2024 TRAM Air program - accelerating them towards commercialisation success. We're deeply grateful to the TRAM Air team for the opportunity, support and recognition of Mirugen's ambitious work.

Congratulations to Ruiye(Alice) Chen and Layal El Wazan for being winners in the 2024 Graeme Clark Institute for Biomedical Engineering Women in STEM Student Awards! The awards recognise and celebrate the achievement and leadership of women graduate student's achievements in the field of biomedical engineering field. We're looking forward to many more of their achievements in the future!

Join pioneering ocular gene therapy researcher Professor Jean Bennett and CERA scientists for an enlightening discussion about the sight-saving potential of gene therapy at the 15th annual Gerard Crock Lecture. 📅 Tuesday 19 November 2024, from 5:45PM 📍Livestream or in-person at the Museum Theatre, Carlton VIC The Gerard Crock Lecture series honours the memory of renowned ophthalmologist, the late Professor Gerard Crock, inaugural Ringland Anderson Professor of Ophthalmology at the University of Melbourne . Professor Bennett is an international authority on the development of gene therapies to treat inherited retinal diseases, which are the most common cause of blindness in working-age people. She has received numerous international awards including the prestigious Champalimaud Foundation Vision Award in 2018. Hear about Professor Bennett’s role leading pivotal research that led to the development of the world’s first approved ocular gene therapy, and the first gene therapy for any purpose approved in Australia – Luxturna, a treatment for a rare genetic form of childhood blindness Leber Congenital Amaurosis. 🧬 Learn about the potential of gene therapy research to transform the lives of people with blinding eye diseases – including the innovative research that is happening here at CERA. Registration is FREE. Join us for a livestream or in-person at the Museum Theatre, Carlton - places are limited. https://lnkd.in/gbEabjrs

Congratulations to our Head of Clinical Biomarkers Research Associate Professor Zhichao Wu on being named a finalist in the Optometry Victoria South Australia Optometrist of the Year Awards!

If you're in Adelaide for The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) conference 2024, you might also be interested in the IRD Breakfast Symposium hosted by Kiora Pharmaceuticals, Inc. and Vision Australia . Associate Professor Lauren Ayton will be presenting alongside Chris Edwards from Vision Australia - who is also a member of CERA's Consumer Advisory Group. https://lnkd.in/gP_mAusg

ORG

AU:ORG:CERA

Centre for Eye Research Australia (CERA)